Skip to main content
🇺🇸 100% Domestic·Synthesized & Shipped in the USABuy 2+ Save 10%·Buy 3+ Save 15%·Buy 5+ Save 20%Free Shipping on Orders Over $200Ships from a U.S. Facility — 1–3 Day ProcessingThird-Party Tested·COAs Available on RequestResearch Grade·≥ 99% Purity Standard🇺🇸 100% Domestic·Synthesized & Shipped in the USABuy 2+ Save 10%·Buy 3+ Save 15%·Buy 5+ Save 20%Free Shipping on Orders Over $200Ships from a U.S. Facility — 1–3 Day ProcessingThird-Party Tested·COAs Available on RequestResearch Grade·≥ 99% Purity Standard
USA Synthesized & Shipped
Third-Party Lab Tested
≥99% Purity Guaranteed
Free US Shipping $200+
NEUROPEPTIDE · RESEARCH HUB

VIP Research Hub — Vasoactive Intestinal Peptide Studies

VIP (vasoactive intestinal peptide) is a 28-residue neuropeptide widely cited in neuro-regulatory, vasodilatory and immune-modulation research literature, signalling primarily through the VPAC1 and VPAC2 receptors.

What this hub covers

  • VPAC1 / VPAC2 G-protein-coupled receptor signalling
  • Neuro-regulatory and vasodilatory research literature
  • Immunomodulatory research models
  • Reconstitution and storage

VIP research articles

Wellness Research

VIP (Vasoactive Intestinal Peptide) Research Overview

Vasoactive Intestinal Peptide (VIP) is a 28-amino acid neuropeptide and potent anti-inflammatory immunomodulator expressed throughout the nervous system, gut, lung, and immune cells — studied for autoimmune disease attenuation, pulmonary arterial hypertension, circadian rhythm regulation, neuroprotection, and acute inflammatory lung injury across decades of preclinical and clinical research.

Read article →

Researchers studying VIP commonly cross-reference these compounds.

VIP research FAQ

What is VIP?
VIP is a 28-amino-acid neuropeptide belonging to the secretin/glucagon superfamily, widely cited in neuro-regulatory, vasodilatory and immune-modulation research.

All content on this hub is provided strictly for laboratory research purposes. Compounds listed are not for human or veterinary consumption. See our research-use disclosure for full terms.